Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04545177 · ClinicalTrials.gov registry record · NA

Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue

A NA study of Glioblastoma, sponsored by Case Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT04545177 is a NA study of Glioblastoma that is active but no longer recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 18 participants, below the 109-participant average among 199 other Glioblastoma trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04545177, a NA study of Glioblastoma, is active but no longer recruiting, sponsored by Case Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

Recent experiments are giving researchers insight into the changes (mutations) that occur in an individual brain tumor cell compared to a normal cell. Currently, we do not have enough knowledge about how uniform these changes are throughout a single brain tumor and if different regions of a brain tumor have different groupings of changes. By obtaining multiple samples of the tumor from various regions during surgery, it will allow researchers to better understand these changes, with the hope that they will lead to new discoveries in the diagnosis and treatment of brain tumors.

Conditions Studied

Interventions

  • DEVICE NICO Myriad and Tissue Preservation System (TPS)

Study Locations (1)

Ohio

  • Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center - Cleveland

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2020-09-17
Est. Completion 2026-06
Phase NA

Sponsor

Case Comprehensive Cancer Center

407 total trials

What the Registry Record Tells You About NCT04545177

The ClinicalTrials.gov registry entry for NCT04545177 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109-participant average among 199 other Glioblastoma trials with a reported enrollment target (83% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glioblastoma appearing as the primary indexed condition, and to 1 intervention - of which NICO Myriad and Tissue Preservation System (TPS) is the first listed.

NCT04545177 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04545177 about?

NCT04545177 is a clinical study titled "Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue". Recent experiments are giving researchers insight into the changes (mutations) that occur in an individual brain tumor cell compared to a normal cell. Currently, we do not have enough knowledge about how uniform these changes are throughout a single brain tumor and if different regions of a brain tu...

What is the current status of trial NCT04545177?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2020-09-17. Estimated completion is 2026-06.

What conditions does trial NCT04545177 study?

This clinical trial studies the following conditions: Glioblastoma.

What interventions are being tested in trial NCT04545177?

The interventions under investigation include: NICO Myriad and Tissue Preservation System (TPS) (DEVICE).

Who is sponsoring clinical trial NCT04545177?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04545177 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glioblastoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.